APA (7th ed.) Citation

James Griffin, Yan Wu, Qingxin Mu, Xinyan Li, & Rodney J. Y. Ho. (2023). Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure. MDPI AG.

Chicago Style (17th ed.) Citation

James Griffin, Yan Wu, Qingxin Mu, Xinyan Li, and Rodney J. Y. Ho. Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure. MDPI AG, 2023.

MLA (9th ed.) Citation

James Griffin, et al. Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure. MDPI AG, 2023.